pyridine and morpholine

pyridine has been researched along with morpholine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duffy, EM; Jorgensen, WL	1
Fotsch, C; St Jean, DJ	1
Cherian, PT; Knittel, JJ; Koikov, LN; Wortman, MD	1

Reviews

1 review(s) available for pyridine and morpholine

Article	Year
Mitigating heterocycle metabolism in drug discovery. Journal of medicinal chemistry, 2012, Jul-12, Volume: 55, Issue:13 Topics: Animals; Biotransformation; Databases, Factual; Drug Discovery; Drug Interactions; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Pharmaceutical Preparations; Rats	2012

Other Studies

2 other study(ies) available for pyridine and morpholine

Article	Year
Prediction of drug solubility from Monte Carlo simulations. Bioorganic & medicinal chemistry letters, 2000, Jun-05, Volume: 10, Issue:11 Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility	2000
Exploring the PI3K alpha and gamma binding sites with 2,6-disubstituted isonicotinic derivatives. Bioorganic & medicinal chemistry letters, 2009, Apr-15, Volume: 19, Issue:8 Topics: Binding Sites; Catalytic Domain; Class Ib Phosphatidylinositol 3-Kinase; Class II Phosphatidylinositol 3-Kinases; Crystallography, X-Ray; Isoenzymes; Isonicotinic Acids; Models, Molecular; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Binding; Pyridines	2009

Article

Year

Prediction of drug solubility from Monte Carlo simulations.

Bioorganic & medicinal chemistry letters, 2000, Jun-05, Volume: 10, Issue:11

Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility

2000

Exploring the PI3K alpha and gamma binding sites with 2,6-disubstituted isonicotinic derivatives.

Bioorganic & medicinal chemistry letters, 2009, Apr-15, Volume: 19, Issue:8

Topics: Binding Sites; Catalytic Domain; Class Ib Phosphatidylinositol 3-Kinase; Class II Phosphatidylinositol 3-Kinases; Crystallography, X-Ray; Isoenzymes; Isonicotinic Acids; Models, Molecular; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Binding; Pyridines

2009